Treatment Sequencing in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer in Japan: A Real-World Observational Study

被引：0
|
作者：
Yasushi Goto
Nobuyuki Yamamoto
Elizabeth T. Masters
Hironori Kikkawa
Jack Mardekian
Robin Wiltshire
Kanae Togo
Yuichiro Ohe
机构：
[1] National Cancer Center Hospital,Department of Thoracic Oncology
[2] Wakayama Medical University,Department of Internal Medicine
[3] Health Economics and Outcomes Research,Medical Affairs, Oncology
[4] Pfizer Inc,Oncology Global Medical Affairs
[5] Pfizer Japan Inc,undefined
[6] Statistics,undefined
[7] Pfizer Inc.,undefined
[8] Pfizer Ltd,undefined
[9] Corporate Affairs,undefined
[10] Health and Value,undefined
[11] Pfizer Japan Inc.,undefined
来源：
Advances in Therapy | 2020年 / 37卷
关键词：
Advanced non-small cell lung cancer; Alectinib; Anaplastic lymphoma kinase; Crizotinib; Medical data vision; Tyrosine kinase inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3311 / 3323
页数：12
相关论文
共 50 条
  • [1] Treatment Sequencing in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer in Japan: A Real-World Observational Study
    Goto, Yasushi
    Yamamoto, Nobuyuki
    Masters, Elizabeth T.
    Kikkawa, Hironori
    Mardekian, Jack
    Wiltshire, Robin
    Togo, Kanae
    Ohe, Yuichiro
    ADVANCES IN THERAPY, 2020, 37 (07) : 3311 - 3323
  • [2] Real World Outcome of Crizotinib for Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer Patients
    Choi, C.
    Kim, Y. J.
    Lee, J. C.
    Kim, S.
    Lee, D. H.
    Yoon, S.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S911 - S911
  • [3] Diagnosis and Treatment of Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer
    Arbour, Kathryn C.
    Riely, Gregory J.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (01) : 101 - +
  • [4] Real-world evidence of lorlatinib therapy in Taiwanese patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer
    Shih, Jin-Yuan
    Luo, Yung-Hung
    Chang, Gee-Chen
    Chang, John Wen-Cheng
    Wang, Chin-Chou
    Yang, Tsung-Ying
    Fang, Wei-Tse
    Shau, Wen-Yi
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2024, 123 (08) : 875 - 881
  • [5] Lorlatinib for the treatment of anaplastic lymphoma kinase-positive non-small cell lung cancer
    Yang, Junyi
    Gong, Weiliang
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (03) : 173 - 178
  • [6] Immunotherapy Following Anaplastic Lymphoma Kinase Inhibitor Therapy for Patients with Anaplastic Lymphoma Kinase-Positive Non-small Cell Lung Cancer in Japan
    Shimomura, Yuki
    Mizutani, Megumi
    Yoshida, Hisako
    Ihara, Yasutaka
    Shintani, Ayumi
    TARGETED ONCOLOGY, 2025, 20 (01) : 171 - 180
  • [7] Treatment of anaplastic lymphoma kinase-positive non-small cell lung cancer: update and perspectives
    Ryser, Christoph Oliver
    Diebold, Joachim
    Gautschi, Oliver
    CURRENT OPINION IN ONCOLOGY, 2019, 31 (01) : 8 - 12
  • [8] Update advances in anaplastic lymphoma kinase-positive non-small cell lung cancer treatment
    Munarriz, Beatriz E. Jimenez
    Khan, Sam
    Li, Yuchen
    Ghazali, Nadia
    Liu, Geoffrey
    CANCER, 2025, 131
  • [9] Treatment Sequencing in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer (NSCLC) in Japan
    Goto, Y.
    Yamamoto, N.
    Masters, E.
    Kikkawa, H.
    Mardekian, J.
    Wiltshire, R.
    Togo, K.
    Ma, H.
    Ohe, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S878 - S879
  • [10] A real-world study of treatment patterns and survival outcome in advanced anaplastic lymphoma kinase-positive non-small-cell lung cancer
    Jin, Ying
    Chen, Yamei
    Yu, Xinmin
    Shi, Xun
    ONCOLOGY LETTERS, 2018, 15 (06) : 8703 - 8710
12345